Form 4 for LMAT LEMAITRE VASCULAR INC
Accepted 2023-03-08 00:00:00 ET · period of report 2023-03-07 · accession 0001437749-23-005807 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2023-03-08 | 2023-03-07 | LMAT | Kamke Trent G | Senior V. P, Ops | M - OptEx | $27.17 | +3,681 | 5,209 | +241% | +$100.0K |
| DM | 2023-03-08 | 2022-03-07+ | LMAT | Kamke Trent G | Senior V. P, Ops | M - OptEx | $0.00 | -3,681 | 4,018 | -48% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-03-07 | M | A | 2,008 | $23.56 | 7,217 | D | — | — | (F1) Represents shares acquired upon exercise of options by the Reporting Person, as reported in Table II. |
| 2 | Common | Common Stock | 2023-03-07 | M | A | 81 | $35.48 | 7,298 | D | — | — | (F1) Represents shares acquired upon exercise of options by the Reporting Person, as reported in Table II. |
| 3 | Common | Common Stock | 2023-03-07 | M | A | 1,592 | $31.30 | 5,209 | D | — | — | (F1) Represents shares acquired upon exercise of options by the Reporting Person, as reported in Table II. |
| 4 | Derivative | Stock Option (Right to Buy) | 2023-03-07 | M | D | 81 | $0.00 | 5,331 | D | $35.48 · 2029-12-20 to 2026-12-20 | 81 Common Stock | (F3) This option is exercisable and vests over a five-year period at a rate of 20% on the first anniversary of the date listed in the table, with the balance vesting in equal annual installments over the remaining four years. |
| 5 | Derivative | Stock Option (Right to Buy) | 2022-03-07 | M | D | 1,592 | $0.00 | 182 | D | $31.30 · 2017-12-22 to 2024-12-22 | 1,592 Common Stock | (F2) This option is fully vested and exercisable. |
| 6 | Derivative | Stock Option (Right to Buy) | 2023-03-07 | M | D | 2,008 | $0.00 | 4,018 | D | $23.56 · 2018-12-19 to 2025-12-19 | 2,008 Common Stock | (F3) This option is exercisable and vests over a five-year period at a rate of 20% on the first anniversary of the date listed in the table, with the balance vesting in equal annual installments over the remaining four years. |